Medical Test Manufacturer
Sold Today for 317% Gain
01/13/2006
Today in our Primary Stock Portfolio we sold
a manufacturer of diagnostic and blood-screening products.
The stock was held for 36 months and its sale resulted in
a gain of 317.1%. Over the same time period, the S&P 500
rose only 38%.
The average sale in our Primary
Stock Portfolio has now resulted in a gain of 91.2% with
74.1% of the trades being profitable.
|
